Workflow
细菌纤维素人工血管
icon
Search documents
最新融资!医用材料企业完成B轮
思宇MedTech· 2025-08-21 09:08
汇涵科技 成立于2005年,总部位于苏州,是一家融合科技、医疗与消费属性的创新型企业,专注于生物医用 材料的研发与产业化。公司旗下有高端敷料、一次性手术器械、生物医用材料及日用消费品四大板块。公司以 临床需求为导向,通过自主核心技术推动医疗产品创新,为手术管理、创面修复及组织再生提供高效解决方 案。 汇涵科技依托 胶体银技术、水凝胶技术、细菌纤维素技术、生物3D技术及MT技术 五大核心平台,为临床医 疗提供高效、安全的解决方案。 公司产品涵盖止血类、手术密封类、防黏连类、软组织管理类等全系列产品,已取得含两个三类医疗器械在内 的 50多张医疗器械注册 。此外,公司还注册了如 细菌纤维素人工血管、细菌纤维素饮品等 新产品,推动创 新材料在临床医疗与大健康领域的应用。 细菌纤维素技术 北京和上海活动报名: 第三届全球手术机器人大会 2025医疗器械研发创新论坛 近日, 苏州汇涵医用科技发展有限公司 (以下简称"汇涵科技")宣布完成 B轮融资 ,此次融资由江苏润淮 产业发展基金独家投资,资金将主要用于汇涵科技旗下生物医用材料板块的产能扩建、自动化升级及研发创 新。 # 关于汇涵科技 融资历程 思宇年度活动回顾: 首 ...
汇涵科技完成B轮融资,江苏润淮产业发展基金投资
Sou Hu Cai Jing· 2025-08-20 07:46
Core Insights - Suzhou Huaihan Medical Technology Development Co., Ltd. (Huaihan Technology) has completed a Series B financing round exclusively funded by Jiangsu Runhuai Industrial Development Fund, aimed at expanding production capacity, upgrading automation, and enhancing R&D in the biomedical materials sector [1][2] - The company, established in 2005, focuses on the research and industrialization of biomedical materials, utilizing five core technology platforms to provide efficient and safe solutions for clinical medicine [1] - The financing will support the construction of a production base for biomedical materials, including products like bio-3D printing inks and biomedical intermediates, while also accelerating automation and intelligent management processes [1] Company Overview - Huaihan Technology has demonstrated strong innovation capabilities and deep industry accumulation over the past 20 years, positioning itself as a benchmark enterprise in China's medical device sector [2] - The company’s products are widely used in surgical hemostasis, wound repair, adhesion prevention, and tissue regeneration, significantly reducing postoperative complications and improving patient recovery efficiency [1] Future Plans - Post-financing, Huaihan Technology will increase R&D investments to register new products such as bacterial cellulose artificial blood vessels and drinks, promoting the application of innovative materials in clinical medicine and the health sector [1] - The strategic partnership with Jiangsu Runhuai Industrial Development Fund aims to enhance market expansion, technological innovation, and capital empowerment, supporting Huaihan Technology in achieving new growth [2]